Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

KROSKROS
Showing 8 of 25 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in KEROS THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 158,712 shares of KROS (KEROS THERAPEUTICS INC), worth $1.7M as of 2026-Q2. The position was decreased (-11.8% shares). KROS represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$1.7M

Current Shares

158,712

Total Value Change

-$13.4M

Total Shares Change

-101,408

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
158,712
-11.8%
$1.7M0.0%$10.70
0
2026-Q1
Decreased
179,952
-3.7%
$2M0.0%$13.40
0
2025-Q4
Decreased
186,779
-36.0%
$3.8M0.0%$20.27
0
2025-Q3
Increased
292,006
+3.0%
$4.6M0.0%$15.95
28
2025-Q2
Increased
283,403
+17.1%
$3.8M0.0%$13.49
31
2025-Q1
Decreased
241,923
-13.5%
$2.5M0.0%$10.79
0
2024-Q4
Increased
279,682
+7.5%
$4.4M0.0%$15.64
29
2024-Q3
Increased
260,120
+14.3%
$15.1M0.0%$56.45
32

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used